Predicting knee pain severity in professional distance runners using gaussian process regression
Source check: Source checked. Not independent scientific confirmation.
Finding: 50 professional runners aged 20–30, self-reported continuous symptom score (not diagnosed injury), 70/30 holdout with train-only 5-fold tuning. Results: held-out MSE .020, RMSE .144, MAE .116, R2 .475 versus mean baseline MSE .047. Small single-cohort sample.
Technology: Gaussian process regression predicts self-reported symptom severity; primary Results explicitly say this is symptom monitoring, not injury diagnosis
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Gaussian process regression predicts self-reported symptom severity; primary Results explicitly say this is symptom monitoring, not injury diagnosis.
- Test and result
- 50 professional runners aged 20–30, self-reported continuous symptom score (not diagnosed injury), 70/30 holdout with train-only 5-fold tuning. Results: held-out MSE .020, RMSE .144, MAE .116, R2 .475 versus mean baseline MSE .047. Small single-cohort sample. Evaluation: Methods: 50 professional runners aged 20–30, self-reported continuous symptom score (not diagnosed injury), 70/30 holdout with train-only 5-fold tuning.
- Limitation / still unknown
- The model predicts self-reported symptom severity in a 50-runner cohort, not diagnosed injury; performance outside this cohort is unknown.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1973629/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.